Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 2 sources · 29 days · First seen · Last updated
Spanish medicinal cannabis and CBD regulation
Overview
The cannabidiol (CBD) and medicinal cannabis sectors in Spain are experiencing regulatory and economic shifts. While the CBD market is growing through industrial hemp production and biochemical analysis, companies must navigate a complex legal environment where European regulations allow the movement of hemp derivatives despite strict local restrictions on certain commercial formats.
In the medical sector, Royal Decree 903/2025 regulates the use of standardized cannabis preparations for therapeutic purposes when conventional treatments fail. Under these rules, products must be registered with the Spanish Agency of Medicines and Medical Devices (AEMPS). To ensure clinical monitoring and controlled dosing, prescriptions are limited to medical specialists, and the preparation and dispensing of these formulas must be handled exclusively through hospital pharmacy services.
Entities
University of São Paulo · Spain · Spanish Agency of Medicines and Medical Devices · Son Espases · Phenosphere
Timeline
-
[HEALTH] 2 sourcesHealthcare updates: Cannabis research in Brazil and digital prescriptions in Spain
Recent healthcare developments include a Brazilian study on medicinal cannabis prescription trends and the expansion of Son Espases hospital's digital patient guidance program in Spain.
-
[HEALTH] 2 sourcesSpain's CBD and medicinal cannabis sectors expand under new regulations
Spain's CBD and medicinal cannabis sectors are expanding amid evolving regulations, including new rules for therapeutic preparations via hospital pharmacies and the AEMPS.
Sources
elplanteo.com · ultimahora.es